Month: April 2019

Data Analytics for cell and gene therapy by Dr. Ruchi Dass, @drruchibhatt

Cell and gene therapies are becoming more and more popular because of encouraging clinical results worldwide. Major pharma manufacturing companies have invested in the concept’s commercialization worldwide. Recently, we read about Takeda’s license for commercialization of Aloficel (developed by TiGenix), Celgene’s acquisition of Juno Therapeutics or Gilead’s acquisition of Kite Pharma.

A roadmap for Academia and Industry Collaboration in Digital Health by Bipinkumar G Rathod, @bipin4uk

Digital health Technology adoption in India is gaining momentum. Many digital health entrepreneurs are providing solutions for hospitals and patients. With India becoming more connected, by becoming one of the largest markets in terms of the mobile phone and broadband densities in the world, many Innovative solutions and Technology ecosystems are being developed for Digital Health interventions.

India’s Health Leapfrog – Towards A Holistic Healthcare Ecosystem Part 1 by Anukriti Chaudhari @AnukritiChaudh2 – @Product_Nation

The leapfrog we envision is that of public, precision healthcare. This means that not only would every citizen have access to affordable healthcare, but the care delivered would be holistic (as opposed to symptomatic) and preventive (and not just curative) in nature.

Scroll to Top
Connect
1
👋 Hello
Hello!! 👋 Manish here, Thanks for visiting The Healthcare IT Experts Blog !! How can i help you?